Results 211 to 220 of about 164,168 (220)
Some of the next articles are maybe not open access.

Inhibition of angiopoietin-like protein 3 as a target for managing hypertriglyceridemia

Current Opinion in Endocrinology, Diabetes & Obesity
Purpose of review To summarize recent advances in therapeutic strategies targeting angiopoietin-like protein 3 (ANGPTL3), a central regulator of triglyceride and remnant lipoprotein metabolism, and to discuss the potential of emerging pharmacologic approaches
Pablo, Corral   +2 more
openaire   +2 more sources

Angiopoietin-Like Protein 3 Inhibition

Journal of the American College of Cardiology
Erik S.G. Stroes   +2 more
openaire   +1 more source

Angiopoietin-like 4 Interacts with Matrix Proteins to Modulate Wound Healing*

Journal of Biological Chemistry, 2010
Yan Yih Goh, Mintu Pal, Han Chung Chong
exaly  

Lipoprotein lipase and angiopoietin-like 4 – Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease

Critical Reviews in Clinical Laboratory Sciences, 2015
Prasanth Puthanveetil   +2 more
exaly  

Angiopoietin-like protein 4: A therapeutic target for triglycerides and coronary disease?

Journal of Clinical Lipidology, 2018
David S Olshan, Daniel J Rader
exaly  

[Role of angiopoietin-like protein (Angptl)].

Seikagaku. The Journal of Japanese Biochemical Society, 2006
openaire   +1 more source

[Progress in the study of angiopoietin-like protein 3].

Sheng li ke xue jin zhan [Progress in physiology], 2010
Xiao-Yan, Zhang, You-Fei, Guan
openaire   +1 more source

Home - About - Disclaimer - Privacy